title: Tissue factor pathway inhibitor and bacterial infection.
abstract: See also van den Boogaard FE, Brands X, Schultz MJ, Levi M, Roelofs JJTH, van 't Veer C, van der Poll T. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia. This issue, pp 122-32.
authors.affiliation: Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201-2178, USA. susan.maroney@bcw.edu
authors.forename: S A
authors.initials: SA
authors.lastname: Maroney
authors.forename: A E
authors.initials: AE
authors.lastname: Mast
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D002443:Ceftriaxone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008074:Lipoproteins / Q000627:therapeutic use*; D011018:Pneumonia, Pneumococcal / Q000097:blood / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000254:growth & development
chemical_list: D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D018836:Inflammation Mediators; D008074:Lipoproteins; D011994:Recombinant Proteins; C051928:lipoprotein-associated coagulation inhibitor; D002443:Ceftriaxone